Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Expression and prognostic significance of thymidylate synthase (TS) in pancreatic head and periampullary cancer.

van der Zee JA, van Eijck CH, Hop WC, van Dekken H, Dicheva BM, Seynhaeve AL, Koning GA, Eggermont AM, Ten Hagen TL.

Eur J Surg Oncol. 2012 Nov;38(11):1058-64. doi: 10.1016/j.ejso.2012.04.013. Epub 2012 May 24.

PMID:
22633450
2.

Differential expression and prognostic value of HMGA1 in pancreatic head and periampullary cancer.

van der Zee JA, ten Hagen TL, Hop WC, van Dekken H, Dicheva BM, Seynhaeve AL, Koning GA, Eggermont AM, van Eijck CH.

Eur J Cancer. 2010 Dec;46(18):3393-9. doi: 10.1016/j.ejca.2010.07.024. Epub 2010 Aug 17.

PMID:
20724141
3.

Bcl-2 associated anthanogen-1 (Bag-1) expression and prognostic value in pancreatic head and periampullary cancer.

van der Zee JA, Ten Hagen TL, Hop WC, van Dekken H, Dicheva BM, Seynhaeve AL, Koning GA, Eggermont AM, van Eijck CH.

Eur J Cancer. 2013 Jan;49(2):323-8. doi: 10.1016/j.ejca.2012.07.030. Epub 2012 Aug 29.

PMID:
22939115
4.

Angiogenesis: a prognostic determinant in pancreatic cancer?

van der Zee JA, van Eijck CH, Hop WC, van Dekken H, Dicheva BM, Seynhaeve AL, Koning GA, Eggermont AM, ten Hagen TL.

Eur J Cancer. 2011 Nov;47(17):2576-84. doi: 10.1016/j.ejca.2011.08.016. Epub 2011 Sep 28.

PMID:
21958461
5.

Thymidylate synthase expression predicts the response to 5-fluorouracil-based adjuvant therapy in pancreatic cancer.

Hu YC, Komorowski RA, Graewin S, Hostetter G, Kallioniemi OP, Pitt HA, Ahrendt SA.

Clin Cancer Res. 2003 Sep 15;9(11):4165-71.

6.
7.

Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma.

Kim K, Chie EK, Jang JY, Kim SW, Han SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW.

Clin Transl Oncol. 2012 May;14(5):391-5. doi: 10.1007/s12094-012-0814-2.

PMID:
22551547
8.

Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.

Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C.

Oncology. 2006;70(5):366-77. Epub 2006 Dec 15.

PMID:
17179731
9.

Thymidylate synthase expression in resectable and unresectable pancreatic cancer: role as predictive or prognostic marker?

Formentini A, Sander S, Denzer S, Straeter J, Henne-Bruns D, Kornmann M.

Int J Colorectal Dis. 2007 Jan;22(1):49-55. Epub 2006 Mar 15.

PMID:
16538493
10.

Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer.

Aguiar S Jr, Lopes A, Soares FA, Rossi BM, Ferreira FO, Nakagawa WT, Carvalho AL, Filho WJ.

Eur J Surg Oncol. 2005 Oct;31(8):863-8.

PMID:
15923105
11.

Expression of thymidylate synthase in cancer of the ampulla of Vater.

Ajiki T, Habara K, Kamigaki T, Nakamura T, Fujino Y, Suzuki Y, Takeyama Y, Kuroda Y, Nakamura T.

Oncol Rep. 2001 Jul-Aug;8(4):759-62.

PMID:
11410778
12.

Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.

Morak MJ, van der Gaast A, Incrocci L, van Dekken H, Hermans JJ, Jeekel J, Hop WC, Kazemier G, van Eijck CH.

Ann Surg. 2008 Dec;248(6):1031-41. doi: 10.1097/SLA.0b013e318190c53e.

PMID:
19092348
13.
14.

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.

Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, Arnaud JP, Gonzalez DG, de Wit LT, Hennipman A, Wils J.

Ann Surg. 1999 Dec;230(6):776-82; discussion 782-4.

15.

Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.

Kornmann M, Schwabe W, Sander S, Kron M, Sträter J, Polat S, Kettner E, Weiser HF, Baumann W, Schramm H, Häusler P, Ott K, Behnke D, Staib L, Beger HG, Link KH.

Clin Cancer Res. 2003 Sep 15;9(11):4116-24.

16.

Thymidylate synthase was associated with patient prognosis and the response to adjuvant therapy in bladder cancer.

Li Y, Li X, Dai H, Sun X, Li J, Yang F, Gu H, Yang Y, Jin Z, Chu Y, Jin X, Kakehi Y, Wu X.

BJU Int. 2009 Feb;103(4):547-52. doi: 10.1111/j.1464-410X.2008.08099.x. Epub 2008 Oct 16.

17.

TS and DPD mRNA levels on formalin-fixed paraffin-embedded specimens as predictors for distant recurrence of rectal cancer treated with preoperative chemoradiotherapy.

Tanaka K, Saigusa S, Toiyama Y, Koike Y, Okugawa Y, Yokoe T, Inoue Y, Kobayashi M, Miki C, Kusunoki M.

J Surg Oncol. 2012 May;105(6):529-34. doi: 10.1002/jso.22123. Epub 2011 Oct 17.

PMID:
22006578
18.

Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer.

Hur H, Kang J, Kim NK, Min BS, Lee KY, Shin SJ, Keum KC, Choi J, Kim H, Choi SH, Lee MY.

Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):669-76. doi: 10.1016/j.ijrobp.2010.06.049. Epub 2010 Oct 6.

PMID:
20932673
19.

Tumour basement membrane laminin expression predicts outcome following curative resection of pancreatic head cancer.

van der Zee JA, van Eijck CH, Hop WC, Biermann K, Dicheva BM, Seynhaeve AL, Koning GA, Eggermont AM, Ten Hagen TL.

Br J Cancer. 2012 Sep 25;107(7):1153-8. doi: 10.1038/bjc.2012.373. Epub 2012 Aug 28.

20.

Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma.

Ren DN, Kim IY, Koh SB, Chang SJ, Eom M, Yi SY, Seong SH, Kim MD, Bronner MP, Cho MY.

J Surg Oncol. 2009 Dec 1;100(7):546-52. doi: 10.1002/jso.21383.

PMID:
19722231

Supplemental Content

Support Center